Skip to main content
Clinical Trials/NCT03839849
NCT03839849
Completed
Not Applicable

Clinical Effectiveness of a Topical Subgingival Application of Injectable Platelet-rich Fibrin as Adjunctive Therapy to Scaling and Root Planing. A Double-blind Split Mouth Randomized Prospective Comparative Controlled Trial

Syrian Private University1 site in 1 country15 target enrollmentFebruary 9, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Periodontal Pockets
Sponsor
Syrian Private University
Enrollment
15
Locations
1
Primary Endpoint
Probing pocket depth (PD)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Clinical evaluation of local administration of injectable PRF (injectable platelet-rich fibrin) in periodontal pockets as adjunctive therapy to scaling and root planing. 15 periodontal patients will receive a through traditional mechanical treatment (scaling and root planing). Each patient will receive subgingival i-PRF injected in half mouth and the opposite side will be injected with saline, immediately after the deep scaling session.

Detailed Description

The aim of the study is to evaluate the efficacy of i-PRF subgingival injection right after scaling and root planing as adjunctive therapy to traditional mechanical therapy. 15 periodontal patients will receive traditional mechanical supra and subgingival scaling and root planing. I-PRF will be applied subgingivally in the deep pockets in a half mouth design. The injected half mouth (study group) for each patient will be allocated randomly. The opposite side will be injected with saline (control group). Clinical parameters will be evaluated: plaque index (PI), bleeding on probing (BOP), probing depth (PD), clinical attachment level (CAL). Clinical measurements will be performed at baseline and at 8 weeks.

Registry
clinicaltrials.gov
Start Date
February 9, 2019
End Date
December 30, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Syrian Private University
Responsible Party
Principal Investigator
Principal Investigator

Hala Albonni

Dr.

Syrian Private University

Eligibility Criteria

Inclusion Criteria

  • Patients are in general good health.
  • Patients are from both gender and are adult.
  • A sign informed consent from participation and permission to use obtained data for research purposes.
  • They have not taken medication known to interfere with periodontal tissue health or healing in the preceding 6 months.
  • Presence of bilateral periodontal pockets (≥5 mm) on the minimum of 2 teeth in each side.

Exclusion Criteria

  • Patients less than 18 years' old
  • Immunosuppressive systemic diseases (like cancer, AIDS, diabetes...)
  • clotting and Hematological disorders
  • Medications influence on the gingival and periodontal tissues (like calcium channel blockers, or Long-term steroid use
  • The teeth with poor bad filling and poorly fitted restorations

Outcomes

Primary Outcomes

Probing pocket depth (PD)

Time Frame: baseline, 2 months

measure as the change in distance from the gingival margin GM to the bottom of the gingival sulcus by using a periodontal probe (UNC 15 "University of North Carolina")

Clinical attachment level (CAL)

Time Frame: baseline, 2 months

measure as the change in distance from the cementoenamel junction to the bottom of the gingival sulcus by using a periodontal probe (UNC 15 "University of North Carolina")

Secondary Outcomes

  • Bleeding on probing (BOP)(baseline, 2 months)
  • full mouth Plaque Index Quigely Hein Index (modified by Turesky et al, 1970)(baseline, 2 months)
  • Modified Gingival Index (Trombelli et al. 2004)(baseline, 2 months)

Study Sites (1)

Loading locations...

Similar Trials